Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00178152
Status:
COMPLETED
Last Update Posted:
2011-05-12
First Post:
2005-09-12
Brief Title:
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
Sponsor:
University of Rochester
Organization:
University of Rochester
Study Overview
Official Title:
The Implication of Erythema Toxicum Neonatorum in Newborns on the Development of Future Asthma
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Erythema Toxicum Neonatorum ETN is a common skin finding that affects healthy full-term babies Several authors have commented on the possible relationship between ETN and the development of atopic conditions such as atopic dermatitis or respiratory disease later in life There is a paucity of research addressing this issue
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None